• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Elon Musk’s Neuralink moving forward with brain implant

Elon Musk’s Neuralink moving forward with brain implant

September 1, 2020 By Sean Whooley

NeuraLink's brain electrode implantation robot
Image: NeuraLink

Elon Musk is touting his Neuralink venture’s “Link” deep brain stimulator implant as a less invasive deep brain stimulation system — disclosing new details about the device.

Neuralink had previously only described its technology in broad strokes, as “ultra-high-bandwidth brain-machine interfaces to connect humans and computers.” During a press conference last year, Musk and company officials said they planned to file for FDA approval for human trials in 2020.

Speaking on a webcast, Musk detailed some aspects of the system. It has a small device with a rechargeable battery meant to last a full day, with wires embedded in the cortical surface of the brain for continuously recording 1,024 channels of neural signals at once. It has a six-axis inertial measurement unit for tracking head movement, more sensors for measurables like temperature, and a Bluetooth antenna to connect with a smartphone app.

A less invasive device than other DBS systems that are implanted around the chest area, Link is implanted through the skull. Musk saying it could be implanted in less than one hour in an outpatient setting and without the use of general anesthesia, with options for removal or upgrades down the line.

In the webcast, Musk showcased three pigs — one without an implant, one with an implant from two months ago and one who previously received an implant. Link accurately predicted the location of the implanted pig’s limbs in real-time while it walked on a treadmill. Additionally, in the display, the implanted pig gave off a sound indicating that areas of its brain associated with its snout were active.

The FDA granted Neuralink breakthrough device designation in July, according to a Medgadget report, and clinical trials could follow after further development, although Musk said the company would have to “significantly exceed” guidelines to get the FDA onside.

Musk has touted the Link system as a potential treatment for spine and brain issues, while also sharing a “wishlist” that includes autism treatment and non-linguistic communication.

Filed Under: Bioelectronic Medicine, Business/Financial News, Featured, Neurological, Neuromodulation/Neurostimulation Tagged With: neuralink

More recent news

  • Edwards earns FDA approval for first-of-its-kind size-adjustable pediatric heart valve
  • Leading medical device experts and MDO launch Medtech Innovation Board
  • Mitria Medical teams with Silicon Valley incubator for mitral repair device
  • Truvian links with Siemens Healthineers to advance benchtop blood testing
  • Medtronic snags breakthrough designation for below-the-knee drug-coated balloon

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy